“Unfortunately, many people could have chronic cardiovascular conditions due to COVID-19 infection — even patients without previous cardiovascular disease, comorbidities, and otherwise low risk of cardiovascular disease,” said Jonathan Whiteson, MD, lead author of the cardiovascular complications guidance statement. “Because of the chronic nature of cardiovascular conditions, there will likely be long-lasting consequences for patients and health systems worldwide.”
The statement was developed by the organization’s PASC Collaborative, a “multidisciplinary group of physicians, clinicians and patient advocates” made to address the need for guidance in caring for long-COVID-19 patients.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
